EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial

Sabina López-Toledo iD, María Cruz Pineda De la Cruz, Itzae Adonai Gutiérrez-Hurtado iD, Ana L Gijón-Soriano, Enrique Martínez-Martínez, Carlos Valencia-Santiago, José E Orellana-Centeno iD, Sergio A Ramírez-García, Royer Pacheco-Cruz

Nutrients · 2025

DOI: 10.3390/nu17040709 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2025. Verfasst von Sabina López-Toledo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Center for Studies in Health Sciences and Disease, "Benito Juarez" Autonomous University of Oaxaca, Oaxaca 68000, Mexico. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Flax, Blood Glucose, Lipid Metabolism. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Type 2 diabetes is a significant health concern in the 21st century, and its prevalence continues to rise despite efforts to promote preventive lifestyle changes. This increase has led to higher economic burdens, prompting the search for non-pharmacological methods to manage glucose levels.

Objective

To assess the effects of flaxseed consumption on biochemical markers (glucose, glycated hemoglobin, total cholesterol, and triglycerides) in adult patients with Type 2 diabetes in Oaxaca, Mexico. Materials and Methods: Participants were recruited and randomized into clinical trials between April and June 2023, and the study protocol was approved by a Human Research Ethics Committee.

Results

Consuming 16 g of flaxseed daily for three months led to a significant decrease in glucose, total cholesterol, and triglyceride levels (p < 0.001) in Type 2 diabetes patients in the intervention group (n = 82). Belonging to the control group (n = 84) was correlated with presenting higher levels of glycated hemoglobin (Spearman’s Rho 0.640; p < 0.001), higher levels of glucose (Spearman’s Rho 0.352; p < 0.001), total cholesterol (Spearman’s Rho 0.796; p < 0.001), and triglycerides (Spearman’s Rho 0.700; p < 0.001).

Conclusions

A daily intake of 16 g of flaxseed is an effective supplementary treatment for adult Mexican patients with Type 2 diabetes, as evidenced by reduced levels of glycated hemoglobin, glucose, cholesterol, and triglycerides in the intervention group. Potential implications for clinical practice: Healthcare providers may consider recommending flaxseed in the diets of patients with obesity, prediabetes, or Type 2 diabetes to improve glucose and lipid metabolism and overall metabolic health.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2FlaxBlood GlucoseLipid MetabolismSeedsHumansMexicoMiddle AgedMaleFemaleGlycated HemoglobinTriglyceridesAdultCholesterolAgedBiomarkers

Stichwörter der Autor:innen

flaxseedglucose metabolismlipid metabolismparallel randomized clinical trialtype 2 diabetes

Substanzen

Blood GlucoseGlycated HemoglobinTriglyceridesCholesterolhemoglobin A1c protein, humanBiomarkers

Autor:innen und Institutionen

  • Center for Studies in Health Sciences and Disease, "Benito Juarez" Autonomous University of Oaxaca, Oaxaca 68000, Mexico.
  • "Presidente Benito Juárez" Hospital, Oaxaca 68040, Mexico.
  • Department of Molecular Biology and Genomics, University Center for Health Sciences, University of Guadalajara, Guadalajara 44340, Mexico.
  • Faculty of Dentistry, "Benito Juarez" Autonomous University of Oaxaca, Oaxaca 68120, Mexico.
  • Faculty of Medicine, "Benito Juarez" Autonomous University of Oaxaca, Oaxaca 68000, Mexico.
  • Faculty of Chemical Sciences, "Benito Juarez" Autonomous University of Oaxaca, Oaxaca 68000, Mexico.

ORCID-Profile: Sabina López-Toledo, Itzae Adonai Gutiérrez-Hurtado, José E Orellana-Centeno

Zitieren

APA

López-Toledo, S., Pineda De la Cruz, M. C., Gutiérrez-Hurtado, I. A., Gijón-Soriano, A. L., Martínez-Martínez, E., Valencia-Santiago, C., Orellana-Centeno, J. E., Ramírez-García, S. A., & Pacheco-Cruz, R. (2025). Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial. Nutrients. https://doi.org/10.3390/nu17040709

Vancouver

López-Toledo S, Pineda De la Cruz MC, Gutiérrez-Hurtado IA, Gijón-Soriano AL, Martínez-Martínez E, Valencia-Santiago C, et al. Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial. Nutrients. 2025. doi:10.3390/nu17040709

BibTeX
@article{LpezToledo2025,
  author = {López-Toledo, Sabina and Pineda De la Cruz, María Cruz and Gutiérrez-Hurtado, Itzae Adonai and Gijón-Soriano, Ana L and Martínez-Martínez, Enrique and Valencia-Santiago, Carlos and Orellana-Centeno, José E and Ramírez-García, Sergio A and Pacheco-Cruz, Royer},
  title = {Flaxseed Improves Glucose and Lipid Metabolism in Mexican Subjects with Type 2 Diabetes: A Parallel Randomized Clinical Trial},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17040709}
}
Kostenlos starten →